Cargando…

2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences

BACKGROUND: Bloodstream infections (BSI) cause significant morbidity and mortality in children, leading to longer hospital stays and increased healthcare costs. Recent epidemiology on national trends and pathogens in children is lacking, which could improve prevention strategies and empiric therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Spaulding, Alicen B, Watson, Dave, Dreyfus, Jill, Bendel-Stenzel, Ellen, Heaton, Phillip, Grapentine, Steve, Kharbanda, Anupam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253561/
http://dx.doi.org/10.1093/ofid/ofy210.1978
_version_ 1783373524028620800
author Spaulding, Alicen B
Watson, Dave
Dreyfus, Jill
Bendel-Stenzel, Ellen
Heaton, Phillip
Grapentine, Steve
Kharbanda, Anupam
author_facet Spaulding, Alicen B
Watson, Dave
Dreyfus, Jill
Bendel-Stenzel, Ellen
Heaton, Phillip
Grapentine, Steve
Kharbanda, Anupam
author_sort Spaulding, Alicen B
collection PubMed
description BACKGROUND: Bloodstream infections (BSI) cause significant morbidity and mortality in children, leading to longer hospital stays and increased healthcare costs. Recent epidemiology on national trends and pathogens in children is lacking, which could improve prevention strategies and empiric therapy selection. METHODS: We conducted a retrospective cohort study utilizing demographic and microbiology data from the Premier Healthcare Database, including all inpatient encounters from 2009–2016 among patients <19 years. BSI were identified via a documented positive blood culture; known contaminants were excluded. Incidence rate was the number of BSI-positive patient encounters per 10,000 admissions. Demographics were analyzed comparing BSI-positive to patients without a documented positive BSI (non-BSI). Hospital-acquired infections were defined as those occurring at least 2 days after admission and analyzed only for non-neonates. Differences were assessed using chi-square tests and t-tests; time trends were analyzed using Cochran-Armitage tests. RESULTS: Among 162 US hospitals reporting ≥4 years of blood cultures, 1,809,722 patient encounters met inclusion criteria; 6,152 (0.34%) had a positive BSI. BSI patients were significantly more often 1–5 years old (16% vs. 6%), and had a complex chronic condition (26% vs. 5%), central line (34% vs. 2%), or catheter (12% vs. 3%) compared with non-BSI patients. Overall BSI incidence rate declined over time (37.0 in 2009 vs. 31.9 in 2016 per 10,000 admissions, P < 0.001). Among non-neonates, pathogens with the highest incidence rates (per 10,000 admissions) were methicillin-susceptible Staphylococcus aureus (MSSA) (10.5), E. coli (10.4), and Streptococcus pneumoniae (6.4); among neonates incidence was highest for E. coli (4.3), Group B Streptococcus (4.0) and MSSA (2.6). Incidence increased significantly over time in two US regions while decreasing in three (Figure 2). CONCLUSION: Hospitalized children remain at risk of community and hospital-acquired BSI. Due to substantial efforts, pediatric BSI incidence has declined nationally in recent years. However, more effective methods to prevent and assess patients at risk for BSI are warranted. [Image: see text] [Image: see text] DISCLOSURES: J. Dreyfus, Premier, Inc.: Employee and Shareholder, Salary.
format Online
Article
Text
id pubmed-6253561
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62535612018-11-28 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences Spaulding, Alicen B Watson, Dave Dreyfus, Jill Bendel-Stenzel, Ellen Heaton, Phillip Grapentine, Steve Kharbanda, Anupam Open Forum Infect Dis Abstracts BACKGROUND: Bloodstream infections (BSI) cause significant morbidity and mortality in children, leading to longer hospital stays and increased healthcare costs. Recent epidemiology on national trends and pathogens in children is lacking, which could improve prevention strategies and empiric therapy selection. METHODS: We conducted a retrospective cohort study utilizing demographic and microbiology data from the Premier Healthcare Database, including all inpatient encounters from 2009–2016 among patients <19 years. BSI were identified via a documented positive blood culture; known contaminants were excluded. Incidence rate was the number of BSI-positive patient encounters per 10,000 admissions. Demographics were analyzed comparing BSI-positive to patients without a documented positive BSI (non-BSI). Hospital-acquired infections were defined as those occurring at least 2 days after admission and analyzed only for non-neonates. Differences were assessed using chi-square tests and t-tests; time trends were analyzed using Cochran-Armitage tests. RESULTS: Among 162 US hospitals reporting ≥4 years of blood cultures, 1,809,722 patient encounters met inclusion criteria; 6,152 (0.34%) had a positive BSI. BSI patients were significantly more often 1–5 years old (16% vs. 6%), and had a complex chronic condition (26% vs. 5%), central line (34% vs. 2%), or catheter (12% vs. 3%) compared with non-BSI patients. Overall BSI incidence rate declined over time (37.0 in 2009 vs. 31.9 in 2016 per 10,000 admissions, P < 0.001). Among non-neonates, pathogens with the highest incidence rates (per 10,000 admissions) were methicillin-susceptible Staphylococcus aureus (MSSA) (10.5), E. coli (10.4), and Streptococcus pneumoniae (6.4); among neonates incidence was highest for E. coli (4.3), Group B Streptococcus (4.0) and MSSA (2.6). Incidence increased significantly over time in two US regions while decreasing in three (Figure 2). CONCLUSION: Hospitalized children remain at risk of community and hospital-acquired BSI. Due to substantial efforts, pediatric BSI incidence has declined nationally in recent years. However, more effective methods to prevent and assess patients at risk for BSI are warranted. [Image: see text] [Image: see text] DISCLOSURES: J. Dreyfus, Premier, Inc.: Employee and Shareholder, Salary. Oxford University Press 2018-11-26 /pmc/articles/PMC6253561/ http://dx.doi.org/10.1093/ofid/ofy210.1978 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Spaulding, Alicen B
Watson, Dave
Dreyfus, Jill
Bendel-Stenzel, Ellen
Heaton, Phillip
Grapentine, Steve
Kharbanda, Anupam
2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences
title 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences
title_full 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences
title_fullStr 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences
title_full_unstemmed 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences
title_short 2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences
title_sort 2325. bloodstream infections in hospitalized children in the united states: incidence, pathogens, and regional differences
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253561/
http://dx.doi.org/10.1093/ofid/ofy210.1978
work_keys_str_mv AT spauldingalicenb 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences
AT watsondave 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences
AT dreyfusjill 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences
AT bendelstenzelellen 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences
AT heatonphillip 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences
AT grapentinesteve 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences
AT kharbandaanupam 2325bloodstreaminfectionsinhospitalizedchildrenintheunitedstatesincidencepathogensandregionaldifferences